To Top

Search By Topic

Alcami

22 Articles available
Donation

Alcami Donation to Outfit TROSA Medical Department

PR-M03-18-NI-065
Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PAP-Q1-18-CL-004
Growth

Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

PR-M02-18-NI-63
Analytical Testing

Analytical Testing — Contractors Take on the Challenge of Complex Molecules

PAO-M01-18-NI-024
Partnership

Alcami to Produce Clinical Supplies of Darinaparsin for Solasia

PAO-M11-17-NI-042
CDMO

Alcami to Manufacture Darinaparsin

PAO-M11-17-NI-016
API

Right-First-Time Innovation Approach Drives Continual Investment

PAP-Q4-17-CL-003
Facility

Alcami Announces Grand Opening of St. Louis, Missouri Facility In Cortex Innovation Community

PR-M09-17-NI-003
Expansion

Alcami Establishes New Center of Excellence

PAO-M09-17-NI-018
Abuse Deterrence

Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

PAP-Q3-17-CL-003
Serialization

Alcami on the Road to BIO: Creating Differentiated Value For Biotechs

Natasha Howard, Site Director, MCC, Alcami. View more about Alcami on the Road to BIO.

PTV-M06-17-CL-009
Regulatory

Implications of Serialization for the U.S. Pharma Industry

PAP-Q2-17-CL-001
Formulation

Partnering for Formulation Development

Elsie Melsopp, Director of Formulation, Alcami

PTV-M11-16-AP-001
CDMO

Understanding Solid State Properties for Formulation Success

PAO-M04-17-NI-001
API

Supporting the Pharma Industry Small Business Growth Engine

PAP-Q1-17-CL-017
CDMO

Keys to Cultural Integration

PAP-Q1-17-QA-001
CDMO

Supply Chain Management and the Importance of Security of Supply

PAP-Q04-16-CL-002
API

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

PAP-Q03-16-CL-005
Design Logic

Alcami: Connected at Every Level

PAP-Q02-16-DL-002
CDMO

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

PAP-Q02-16-CL-011
API

Strengthening CDMOs to Meet Industry Needs for 2016 and Beyond

PAP-Q1-16-CL-001
API

Bolstering Capabilities for Parenteral Drug Development and Manufacturing

PAP-Q4-15-CL-005